Skip to search boxSkip to navigationSkip to main content

Clinical-epidemiologic variation in patients treated in the first and second wave of COVID-19 in Lambayeque, Peru: A cluster analysis

  • Mario J. Valladares-Garrido
    ,
  • Virgilio E. Failoc-Rojas(corresponding author)
    ,
  • Percy Soto-Becerra
    ,
  • Sandra Zeña-Ñañez
    ,
  • ,
  • Jorge L. Fernández-Mogollón
*Corresponding author for this work
  • Universidad Privada Norbert Wiener
    ,
  • Instituto de Evaluación de Tecnologías en Salud e Investigación, EsSalud
    ,
  • Universidad San Ignacio de Loyola
    ,
  • Universidad Continental, Huancayo
    ,
  • ,
  • Hospital Nacional Almanzor Aguinaga Asenjo, EsSalud
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 212-220 (9 pages)

Journal (Volume, Issue Number)

International Journal of Infectious Diseases (Volume 123)

Publication milestones

  • Published - 10/2022

Publication status

Published - 10/2022

ISSN

1201-9712

Publication IDs

  • Scopus: 85138820559
  • PubMed: 35872099

Abstract

Objectives: To identify differences in the clinical and epidemiologic characteristics of patients during the first and second waves of the COVID-19 pandemic at the EsSalud Lambayeque health care network, Peru. Methods: An analytical cross-sectional study of 53,912 patients enrolled during the first and second waves of COVID-19 was conducted. Cluster analysis based on clustering large applications (CLARA) was applied to clinical-epidemiologic data presented at the time of care. The two pandemic waves were compared using clinical-epidemiologic data from epidemiologic surveillance. Results: Cluster analysis identified four COVID-19 groups with a characteristic pattern. Cluster 1 included the largest number of participants in both waves, and the participants were predominantly female. Cluster 2 included patients with gastrointestinal, respiratory, and systemic symptoms. Cluster 3 was the “severe” cluster, characterized by older adults and patients with dyspnea or comorbidities (cardiovascular, diabetes, obesity). Cluster 4 included asymptomatic, pregnant, and less severe patients. We found differences in all clinical-epidemiologic characteristics according to the cluster to which they belonged. Conclusion: Using cluster analysis, we identified characteristic patterns in each group. Respiratory, gastrointestinal, dyspnea, anosmia, and ageusia symptoms were higher in the second COVID-19 wave than the first COVID-19 wave.

Funding Details

This study was supported by the Instituto de Evaluación de Tecnologías en Salud e Investigación (IETSI), EsSalud, Peru.
FundersFunding numbers
EsSalud
-
Instituto de Evaluación de Tecnologías en Salud en Investigación
-

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Citations
15
Captures
35

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well